EB
SLDB icon

Eastern Bank’s Solid Biosciences SLDB Stock Holding History

Eastern Bank’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51K Buy
+151
New +$1.15K ﹤0.01% 982

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Eastern Bank's SLDB Position: Q2 2026 in Review

Eastern Bank opened a new position in Solid Biosciences (SLDB) in Q2 2026: 151 shares worth $1.51K. The stake represents ﹤0.01% of the portfolio and ranks #982 among its holdings.

157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Eastern Bank held 151 shares of Solid Biosciences worth $1.51K as of Q2 2026.
  • Solid Biosciences was a new Eastern Bank position in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #982 holding.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.